From blurriness to progressive vision loss in eye, know when to visit your eye doctor. Explore. Search Thursday, Jun 12, 2025. New Delhi o C. Subscribe. Games. E-Paper Sign in. My Account ...

In what it claims to be a "world's first," Dentsu this morning announced it has completed the integration of consumer eye-tracking data in retail locations into its proprietary media planning system.

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.

Brain scans show that eye contact activates parts of the brain linked to reading others’ feelings and intentions, including the fusiform gyrus, medial prefrontal cortex, and amygdala.

Nvidia is poised to capture the lion's share of revenue. At full capacity, the Abilene facility could require as many as 400,000 of Nvidia's next-generation GB200 GPUs, potentially generating ...

Despite heavy volatility, Rivian (NASDAQ: RIVN) share prices have jumped nearly 20% in value over the past year. Apart from revenue growth, however, there are two other numbers that investors ...

Japanese scientists create a self-powered artificial eye using solar cell tech, accurately detecting colour and motion, promising efficient sensors and devices. Thursday, Jun 26, 2025.

Tesla (NASDAQ: TSLA) has long been a volatile stock, but it's also become a very controversial name in recent months. If you're monitoring Tesla stock, here are two numbers you need to be tracking.

SAN ANTONIO, June 03, 2025--AirStrip®, a leader in clinical surveillance, decision support, and alarm management solutions, today announced the acquisition of Fifth Eye, the developer of the FDA ...

RCB have qualified for the final thrice in history - 2009, 2011 and 2016 - but lost on all occasions. RCB will play Punjab Kings in the final of IPL 2025 in Ahmedabad.

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have been no FDA-approved (or other) treatments to slow or stop vision loss.